• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    More On SSS.V

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Stem Cell Therapeutics Corp. (SSS.V)

    -TSXV
    0.38 Up 0.04(10.29%) Apr 21
    Add to Portfolio
    Prev Close:0.34
    Open:0.33
    Bid:0.36
    Ask:0.38
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.33 - 0.38
    52wk Range:0.14 - 0.74
    Volume:236,350
    Avg Vol (3m):194,889
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Stem Cell Therapeutics Corp., a biopharmaceutical development company, advances cancer stem cell discoveries into novel and cancer therapies in Canada. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback